| Investment Team | |||
![]() Rolf C. Dienst |
![]() Lukas Guenther |
![]() Erich Schlick |
![]() Rainer Strohmenger |
![]() Thomas Widmann |
|||
| Venture Partners | |||
![]() Ulrich Granzer |
![]() Mohammad Naraghi |
![]() Melvin Spigelman |
|
![]() |
|||
![]()
It takes years of in-depth industry involvement to understand the latest developments in Life Sciences. Our team members are Life Sciences practitioners and investors with vast operative and entrepreneurial experience. They understand the key issues that are involved in building sustainable companies – from preclinical/clinical development and regulatory affairs right through to team building, market entry, financing and value creation.
The investment team is supported by our Venture Partner network in Europe and the United States. It consists of well-established, highly networked professionals who are active in the sectors that are of relevance for our portfolio companies. Our Venture Partners provide three dimensions of assistance: First, by benchmarking the investment opportunities against the global best of breed. Second, by helping us connect our portfolio companies with the top levels at relevant market players so that we can truly jump-start our companies’ expansion strategies. Third, by bringing the right people into our companies, thus steadily enriching the available talent pool and adapting at any time to the challenges over the course of a company’s development.









